Clinical trial Recruiting at 6 sites Observational Ages 18 and up

Improving eye disease treatment through data sharing and analysis

Official title: EyeMatics - Eye Diseases "Treated" With Interoperable Medical Informatics

Run by University Hospital Muenster · NCT06810011 · Data updated 2026-11-12

This study is trying to see if sharing and analyzing eye disease treatment data can help doctors provide better personalized care for patients receiving intravitreal injections.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment2000 (estimated)
SponsorUniversity Hospital Muenster
Academic / other
Locations6 sites (Chemnitz, Saxony and 5 other locations)
StatusRecruiting
StartedMarch 1, 2024
Main results expectedFebruary 29, 2028
Study endsFebruary 29, 2028
Registry record updatedFebruary 5, 2025
Trial IDNCT06810011 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients undergoing intravitreal injections for eye diseases.

Probably not a fit

Patients not receiving intravitreal injections or those with unrelated eye conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The EyeMatics project aims to create a sustainable infrastructure for integrating and sharing clinical research data to enhance personalized medicine in ophthalmology. By collaborating with multiple ophthalmological centers of excellence in Germany, the initiative focuses on understanding the therapeutic success of eye diseases treated with intravitreal injections. The project will develop a web-based dashboard for visualizing and analyzing real clinical data, incorporating patient feedback to improve quality of life and treatment outcomes.

Why it matters

Potential benefit: If successful, this project could lead to more effective and personalized treatments for patients with eye diseases.

How similar studies have gone: Other studies utilizing data sharing and artificial intelligence in healthcare have shown promise, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* OPS code: "5-156.9 Injection of drugs into the posterior segment of the eye"

Where it's running

  • Klinikum Chemnitz gGmbH
    Chemnitz, Saxony, Germany
    Recruiting
  • Universitätsklinikum Aachen, AöR
    Aachen, Germany
    Recruiting
  • Universitätsmedizin Greifswald
    Greifswald, Germany
    Recruiting
  • Universität Leipzig
    Leipzig, Germany
    Recruiting
  • Universität Münster
    Münster, Germany
    Recruiting
  • Universitätsklinikum Tübingen
    Tübingen, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.